Jefferies raises Jefferies Alnylam price target to $260
Jefferies raised its price target on Alnylam Pharmaceuticals to $260.00 per share from $230.00 and maintained a Hold rating, according to Benzinga/TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.